| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/16/2004 | CA2525752A1 Cannabinoid receptor ligands and uses thereof |
| 12/15/2004 | EP1486508A1 Use of the AL-1 neurotrophic factor, a ligand for an EPH-related tyrosine kinase receptor, for the preparation of a medicament for modulating angiogenesis associated disease or condition |
| 12/15/2004 | EP1486503A1 Derivatives of benzothiazine and benzothiadiazine, procedure for their preparation and pharmaceutical compositions containing them |
| 12/15/2004 | EP1486502A1 Derivatives of benzothiazine and benzothiadiazine, procedure for their preparation and pharmaceutical compositions containing them |
| 12/15/2004 | EP1486501A1 Aminomethyl-substituted thiazolobenzimidazole derivative |
| 12/15/2004 | EP1486497A1 Novel pyridone derivative |
| 12/15/2004 | EP1486491A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient |
| 12/15/2004 | EP1486490A1 Azole compounds |
| 12/15/2004 | EP1486214A1 Botulinum toxins for treating muscle spasm |
| 12/15/2004 | EP1486206A1 New uses for amino acid anticonvulsants for treatment of bipolare disorder |
| 12/15/2004 | EP1486205A1 New uses for amino acid anticonvulsants for treatment of migraine |
| 12/15/2004 | EP1485390A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors |
| 12/15/2004 | EP1485388A2 Topiramate salts and compositions comprising and methods of making and using the same |
| 12/15/2004 | EP1485386A2 Pyridinyloxy derivatives as 5-ht receptor ligands |
| 12/15/2004 | EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators |
| 12/15/2004 | EP1485383A1 Process for preparing crystalline form i of cabergoline |
| 12/15/2004 | EP1485379A1 Beta 3-adrenergic receptor agonists |
| 12/15/2004 | EP1485377A1 Pyranones useful as atm inhibitors |
| 12/15/2004 | EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485368A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity |
| 12/15/2004 | EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485363A1 Cyclic amides |
| 12/15/2004 | EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485353A1 New inhibitors of histone deacetylase |
| 12/15/2004 | EP1485352A1 Azaspiro compounds for the treatment of pain |
| 12/15/2004 | EP1485347A2 Hif hydroxylase inhibitors |
| 12/15/2004 | EP1485132A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 12/15/2004 | EP1485127A2 Administration of agents for the treatment of inflammation |
| 12/15/2004 | EP1485122A2 Novel application of vaccination against tnf-alpha |
| 12/15/2004 | EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 12/15/2004 | EP1485105A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent |
| 12/15/2004 | EP1485104A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 12/15/2004 | EP1485101A1 Non-sedating barbituric acid derivatives |
| 12/15/2004 | EP1485099A1 Inhibitors of histone deacetylase |
| 12/15/2004 | EP1485098A1 Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo[1,5-b]pyridazine in nanoparticulate form |
| 12/15/2004 | EP1485093A1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 12/15/2004 | EP1485092A1 Use of rapamycin for inhibiting of cell death |
| 12/15/2004 | EP1485089A1 Combination treatments for chemokine-mediated diseases |
| 12/15/2004 | EP1485088A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 12/15/2004 | EP1485087A1 (+)-2- 1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 12/15/2004 | EP1485086A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane as nmda, 5ht3, and neuronal nicotinic receptor antagonists |
| 12/15/2004 | EP1485085A1 Phosphate prodrugs of fluorooxindoles |
| 12/15/2004 | EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
| 12/15/2004 | EP1485081A1 Ibuprofen solution for hard shell capsules |
| 12/15/2004 | EP1485078A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes |
| 12/15/2004 | EP1485074A2 Compositions for treating digestive functional pathologies |
| 12/15/2004 | EP1485051A1 Method of administering buprenorphine to treat depression |
| 12/15/2004 | EP1485050A2 A substance with sedative effect |
| 12/15/2004 | EP1409476B1 Pharmaceutical compounds with serotonin receptor activity |
| 12/15/2004 | EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals |
| 12/15/2004 | EP1399155A4 Small molecules useful in the treatment of inflammatory disease |
| 12/15/2004 | EP1387840B1 3,5-diamino-1,2,4-triazoles as kinase inhibitors |
| 12/15/2004 | EP1373216B1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 12/15/2004 | EP1322300B1 Inhalation particles incorporating a combination of two or more active ingredients |
| 12/15/2004 | EP1317427B1 Method for producing chiral compounds |
| 12/15/2004 | EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 12/15/2004 | EP1307447B1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 12/15/2004 | EP1301517B1 Thienopyrrolidinones |
| 12/15/2004 | EP1263711B1 Novel use of phenylheteroalkylamine derivatives |
| 12/15/2004 | EP1249245B1 Remedies and/or preventives for nervous system disorders |
| 12/15/2004 | EP1237566B1 Intraspinal compositions containing botulinum toxin for treating pain |
| 12/15/2004 | EP1226160B1 Novel antiarrhythmic peptides |
| 12/15/2004 | EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 12/15/2004 | EP1175222B1 Monthly doses of glycopeptide antibiotics for long-term prevention of streptococcus pneumoniae infections |
| 12/15/2004 | EP1149063B1 Ureido-thiobutyric acid derivatives as ppar-agonists |
| 12/15/2004 | EP1126841B1 Combinations of a 5ht1b/1d agonist and a selective cox-2 inhibitor for the treatment of migraine |
| 12/15/2004 | EP1119543B1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 12/15/2004 | EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
| 12/15/2004 | EP1047415B1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 12/15/2004 | EP0938304B1 Isovaleramide for the treatment of convulsions, epilepsy, headache and spasticity |
| 12/15/2004 | EP0837874B1 Neuroactive steroids of the androstane and pregnane series |
| 12/15/2004 | CN1555377A 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 12/15/2004 | CN1555376A 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 12/15/2004 | CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives |
| 12/15/2004 | CN1555370A Process for the preparation of 5-substituted isobenzofurans |
| 12/15/2004 | CN1555367A 3-substituted-4-pyrimidone derivatives |
| 12/15/2004 | CN1555356A Bisphenol derivative as NHE-3 inhibitor |
| 12/15/2004 | CN1555355A Substituted 4-aminocyclohexanol derivatives |
| 12/15/2004 | CN1555351A Method for the preparation of unsaturated hydroxy fatty acids and their esters, their use in pharmaceutical and/or cosmetic preparations |
| 12/15/2004 | CN1555266A Hormone replacement therapy |
| 12/15/2004 | CN1555264A Formulations for treatment of mucosal associated conditions with an immune response modifier |
| 12/15/2004 | CN1555262A Novel 4,5-dihydro-1H-pyrazole derivatives having CB*-antagonistic activity |
| 12/15/2004 | CN1555260A Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
| 12/15/2004 | CN1555259A use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders |
| 12/15/2004 | CN1555258A Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 12/15/2004 | CN1554656A Yunnan tolal biological coronaridine and its salts and preparing method and use |
| 12/15/2004 | CN1554654A Synthetic method for thiagabine and its raceme and S-configuration and its method for preparing amorphous powder |
| 12/15/2004 | CN1554649A Metabotropic glutamate receptor antagonists for treating central nervous system diseases |
| 12/15/2004 | CN1554431A Restoring consciousness freezo-dried powder injection for injection and its preparing method |
| 12/15/2004 | CN1554427A Process for preparing Chinese herbal medicine yellow ligusticum and use |
| 12/15/2004 | CN1554426A Oral medicine for treating child restless syndrome |
| 12/15/2004 | CN1554425A Oral medicine for treating dementia and feeblemindedpess |
| 12/15/2004 | CN1554403A Maitong pill |
| 12/15/2004 | CN1554401A Use of seguinii in preparing medicine or food |
| 12/15/2004 | CN1554400A Use of seniawinii in preparing anti-depression, improving brain or/and defatting medicine or food |
| 12/15/2004 | CN1554399A Use of Hubei erectum in preparing anti-depression, anti-anxiety or/and improving, brain medicine or food |
| 12/15/2004 | CN1554349A Dry mix formulation for bisphosphonic acids |
| 12/15/2004 | CN1554342A Complementary gain pain-killing medicine |
| 12/15/2004 | CN1179970C Purine derivatives |
| 12/15/2004 | CN1179962C Azaindolizinone derivatives and cerebral function improvers containing the same as the active ingredient |